Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Lineage Cell Therapeutics Zoomed Higher Today

TheMotleyFool

0 0

Why Lineage Cell Therapeutics Zoomed Higher TodayPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

Clinical-stage biotech Lineage Cell Therapeutics (NYSEMKT: LCTX) was a bright spot during a dark session for the overall stock market. The company's shares rocketed upward by more than 21% on Monday on news of a collaboration agreement with a large and deep-pocketed partner.

On Monday morning, Lineage disclosed that it and its Cell Cure Neurosciences subsidiary had signed a global collaboration and licensing deal with two units of Swiss healthcare powerhouse Roche Holding (OTC: RHHBY).

Image source: Getty Images.

Source Fool.com

Like: 0

LCTX

Teilen